APOL1 Renal-Risk Variants Do Not Associate With Incident Cardiovascular Disease or Mortality in the Systolic Blood Pressure Intervention Trial

by Barry I. Freedman, Michael V. Rocco, Jeffrey T. Bates, Michel Chonchol, Amret T. Hawfield, James P. Lash, Vasilios Papademetriou, John R. Sedor, Karen Servilla, Paul L. Kimmel, Barry M. Wall, Nicholas M. Pajewski
Published 2017-07-01